Skip to content

Cenomate 50 mg

Generic: Cenobamate

Company: Everest Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength50 mg
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated June 23, 2025.

Compare

Same generic, same strength

Sorted by price per unit. Ask your pharmacist before you switch brands.

Cenobamate 50 mg unit

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Cenobamate guide

Indications

Cenobamate is indicated for the treatment of partial-onset seizures in adult patients.

Dosage and administration

Cenobamate can be taken with or without food, or as recommended by a physician. Recommended dosage for partial-onset seizures in adult- Initial Dosage: For Week 1 and 2 dose is 12.5 mg once daily Titration Regimen: For Week 3 and 4 dose is 25 mg once daily For Week 5 and 6 dose is 50 mg once daily For Week 7 and 8 dose is 100 mg once daily For Week 9 and 10 dose is 150 mg once daily Maintenance Dosage: For Week 11 and thereafter dose is 200 mg once daily Maximum Dosage: If needed based on clinical response and tolerability, the dose may be increased above 200 mg by increments of 50 mg once daily every two weeks to 400 mg once daily.

Side effects

Common: Somnolence, fatigue, dizziness or feeling sleepy, nausea, constipation, double vision, decreased appetite, diarrhea, or weakness may occur. Rare: A very serious allergic reaction to Afalino is rare.

Precautions and warnings

Potential adverse effects such as Multiorgan hypersensitivity reaction, QT shortening, and Suicidal thoughts. Somnolence and fatigue should be periodically re-evaluated. During Afalino therapeutic regimen, patients are advised not to drive or operate machinery. Afalino should be gradually withdrawn to minimize the potential or increased seizure frequency. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) / Multi-Organ Hypersensitivity: Discontinue if no alternate etiology. QT Shortening: Use caution when administering Afalino with other drugs that shorten the QT interval Suicidal Behavior and Ideation: Monitor patients for suicidal behavior and ideation. Neurological Adverse Reactions: Monitor for somnolence and fatigue and advise patients not to drive or operate machinery until they have gained sufficient experience on Afalino. Concomitant use with other CNS depressants or alcohol may have additive effects. Withdrawal of Antiepileptic Drugs: Afalino should be gradually withdrawn to minimize the potential of increased seizure frequency

Pregnancy and lactation

There are no adequate and well-controlled studies in pregnant women with the use of Cenobamate. But it may cause fetal harm when administered to a pregnant woman. It should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. There are no data on the presence of Cenobamate in human milk, the effects of Cenobamate on the breastfed infant, or the effects of Cenobamate on milk production.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250